Senior Vice President, Corporate Development and Strategy
Currax Pharmaceuticals LLC
Henderson, United States
Hope Mueller is a pharmaceutical executive, author, and small business owner. As the SVP, Corporate Development and Strategy at Currax Pharmaceuticals, she brings over 25 years of healthcare leadership experience directing corporate strategy, business development, communications, continuous improvement, operations, and quality.
Prior to joining Currax, Hope served in various VP roles at Horizon Therapeutics, ranging from VP of Quality to VP of R&D Program and Project Management. Hope transitioned from Catalent to Crealta Pharmaceuticals (acquired by Horizon) to lead Quality, Operations, and Due Diligence and Integration.
At Catalent, Hope scaled her level of responsibility, starting from leading all of the analytical laboratories to tackling the role of Site Head of Quality. At Baxter Healthcare, in five years, she ascended from a Microbiology Analyst, through Supervisor and Manager roles, to a Senior Manager of Quality Improvement, where she drove process improvements across eight global sites. She started her career in the microbiology laboratories at Cook Pharmaceuticals and Eli Lilly.
Hope received her Bachelor of Science degree from Indiana University Bloomington in Biology, and her MBA from Northwestern University Kellogg School of Management, and Corporate Communications Certifcation from eCornell. She is the Founder and President of Hunter Street Charity, Hunter Street Press, and CLIMB Conferences.
Disclosure information not submitted.
The Pharmacoepidemiologist's Toolbox for Professional Empowerment
Saturday, August 24, 2024
9:00 AM – 12:30 PM CEST